N. Jeppesen

Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin and urokinase.

P. Mogensen, F. Lundbeck, N. Jeppesen, 1983, The Journal of urology.

Phase II Study of a 3-Day Schedule with Topotecan and Cisplatin in Patients with Previously Untreated Small Cell Lung Cancer and Extensive Disease

P. B. Jensen, U. Lassen, S. Langer, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.

F. Hirsch, H. Hansen, P. Dombernowsky, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

16 Randomized trial in small cell lung cancer comparing the combination of cisplatin and carboplatin with carboplatin alone in combination chemotherapy

F. Hirsch, H. Hansen, P. Dombernowsky, 1997 .

88 Oral etoposide (VP-16) every 3 wks. or continuously to elderly patients with small cell lung cancer (SCLC): Preliminary results of a randomized study

F. Hirsch, P. Dombernowsky, B. Bergman, 1997 .

Estimation of kidney function in cancer patients.

K. Stokholm, Belén Redal-Baigorri, K. Rasmussen, 2011, Danish medical bulletin.

Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan

M. Mau-Sørensen, S. Langer, C. Rytter, 2023, Acta oncologica.

Avelumab (MSB0010718C; anti-PD-L1) vs platinum-based doublet as first-line treatment for metastatic or recurrent PD-L1-positive non-small-cell lung cancer: The phase 3 JAVELIN Lung 100 trial.

N. Pavlakis, Michael Thomas, P. Postmus, 2016 .